How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Left Atrial Appendage Closure System Market
- By Product Type: Percutaneous Left Atrial Appendage Closure Devices, Surgical Left Atrial Appendage Closure Devices, Hybrid Closure Systems
- By Device Material: Nitinol-Based Devices, Polymer-Coated Devices, Titanium-Based Devices
- By End User: Hospitals, Cardiology Clinics, Ambulatory Surgical Centers
- By Indication: Non-Valvular Atrial Fibrillation, Valvular Atrial Fibrillation, Stroke Prevention in Atrial Fibrillation
- By Procedure Type: Minimally Invasive Procedures, Open Heart Surgery Procedures
Top segment
Percutaneous Left Atrial Appendage Closure Devices XX% share · $X,XXXM
In the full report →
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Percutaneous Left Atrial Appendage Closure Devices leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 272 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.169 →
- 12 Company Profiles 12 players: SWOT & benchmarking p.177 →
Full report · locked preview
Everything inside the Left Atrial Appendage Closure System Market report
A complete, evidence-based study - 12 chapters and 114 sections covering market size, segmentation across 5 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Product Type 3
Device Material 3
End User 3
Indication 3
Procedure Type 2
Companies profiled
Boston Scientific Corporation
Abbott Laboratories
SentreHEART Inc.
Lifetech Scientific Corporation
Cardia Innovation AB
LivaNova PLC
Biosense Webster
Inc. (Johnson & Johnson)
MicroPort Scientific Corporation
Shanghai Shape Memory Alloy Co. Ltd.
Lepu Medical Technology (Beijing) Co. Ltd.
Zhejiang Aorui Medical Technology Co. Ltd.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →SentreHEART Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Lifetech Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Cardia Innovation AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →LivaNova PLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Biosense Webster
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Inc. (Johnson & Johnson)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →MicroPort Scientific Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Shanghai Shape Memory Alloy Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Lepu Medical Technology (Beijing) Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Zhejiang Aorui Medical Technology Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,270M by 2033 · 4.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Percutaneous Left Atrial Appendage Closure Devices52.6
- Surgical Left Atrial Appendage Closure Devices24.5
- Hybrid Closure Systems22.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$536.0M → $844.5M · 5.8%
Europe$373.6M → $537.9M · 4.7%
Asia Pacific$341.1M → $462.1M · 3.9%
Latin America$211.2M → $331.1M · 5.8%
Middle East and Africa$162.4M → $246.2M · 5.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.232026
4.242027
4.242028
4.262029
4.282030
4.282031
4.302032
4.322033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Boston Scientific Corporation15.7
- Abbott Laboratories17.4
- SentreHEART Inc.6.9
- Lifetech Scientific Corporation8.0
- Cardia Innovation AB12.4
- LivaNova PLC11.5
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type24.7%
Device Material21.4%
End User19.7%
Indication12.7%
Procedure Type21.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.9
- Europe22.2
- Asia Pacific19.1
- Latin America13.7
- Middle East and Africa10.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 75 | 98 | 96 | 77 | 93 | 88 | 88 |
| Abbott Laboratories | 84 | 81 | 69 | 71 | 84 | 68 | 76 |
| SentreHEART Inc. | 75 | 85 | 83 | 84 | 72 | 69 | 78 |
| Lifetech Scientific Corporation | 81 | 66 | 61 | 63 | 62 | 58 | 65 |
| Cardia Innovation AB | 61 | 59 | 56 | 66 | 64 | 70 | 63 |
| LivaNova PLC | 69 | 66 | 64 | 46 | 58 | 55 | 60 |
| Biosense Webster | 51 | 47 | 59 | 45 | 65 | 59 | 54 |
| Inc. (Johnson & Johnson) | 42 | 50 | 54 | 51 | 58 | 40 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Boston Scientific Corporation
- Abbott Laboratories
- SentreHEART Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | ◐ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Abbott Laboratories | ◐ | ✓ | − | ◐ | ✓ | ◐ |
| SentreHEART Inc. | ✓ | ◐ | ✓ | ✓ | ◐ | − |
| Lifetech Scientific Corporation | ✓ | ◐ | ◐ | − | − | ◐ |
| Cardia Innovation AB | ◐ | − | − | ◐ | ◐ | − |
| LivaNova PLC | ✓ | ◐ | ◐ | − | − | ◐ |
| Biosense Webster | − | − | ◐ | − | ◐ | ◐ |
| Inc. (Johnson & Johnson) | − | − | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Boston Scientific Corporation88
2SentreHEART Inc.78
3Abbott Laboratories76
4Lifetech Scientific Corporation65
5Cardia Innovation AB63
6LivaNova PLC60
7Biosense Webster54
8Inc. (Johnson & Johnson)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Boston Scientific CorporationSentreHEART Inc.
Challenger1
Strong scale, closing on the leaders.
Abbott Laboratories
Contender3
Focused players with pockets of strength.
Lifetech Scientific CorporationCardia Innovation ABLivaNova PLC
Niche2
Specialists in a single segment or region.
Biosense WebsterInc. (Johnson & Johnson)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Left Atrial Appendage Closure System Market — a $230M beachhead inside a $3.84B market.
Beachhead (SOM)$230Mobtainable near-term
Serviceable (SAM)$1.34Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Percutaneous Left Atrial Appendage Closure Devices
Best fit — highest urgency & budget in Product Type.
Economic buyer79 fit
Surgical Left Atrial Appendage Closure Devices
Strong fit — clear ROI and a fast path to value.
End user68 fit
Hybrid Closure Systems
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Device Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel28%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Left Atrial Appendage Closure System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified23%
Evaluation12%
Closed-won5%
$8.5KCAC
$49KLTV
5.8:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Left Atrial Appendage Closure System Market is a durable-growth opportunity — $3.54B by 2033, compounding at 8.1%.
TAM · 2025$1.91Btoday
TAM · 2033$3.54Bforecast
CAGR8.1%2027–2033
Cumulative$23.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.54BTotal addressable market
SAM$1.43BServiceable available market
SOM$264MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.1% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.54BLarge & growingTAM by 2033 at 8.1% CAGR
$1.43BServiceable nowreachable with today’s model
$264MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.76BBear5.2% CAGR
$3.54BBase8.1% CAGR
$4.54BBull10.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Device Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Left Atrial Appendage Closure System Market — a $7.74B market by 2033. Plan: grow share from 9.2% to 19.0%.
Market size · 2033$7.74Btotal addressable
Market CAGR10.0%2027–2033
Target share19.0%from 9.2% today
Revenue ambition$1.47Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.2% | 19.0% | On track |
| Revenue | $777M | $1.47B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.9% | 43.0% | Ahead |
| Customer retention | 88.4% | 96.6% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Device Material capability
A defensible second engine — invest in Device Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Device Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $218M capacity & capability investment
- Greenlight bolt-on M&A in Device Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Left Atrial Appendage Closure System Market conversation — a $2.02B market you can size, segment and defend in minutes.
Market size · 2033$2.02Btotal opportunity
Growth8.4%CAGR to 2033
Addressable buyers932+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 2 mopayback period
$42K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
Boston Scientific CorporationAbbott LaboratoriesSentreHEART Inc.Lifetech Scientific CorporationCardia Innovation ABLivaNova PLCBiosense WebsterInc. (Johnson & Johnson)+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Left Atrial Appendage Closure System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Left Atrial Appendage Closure System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Left Atrial Appendage Closure Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportLeft Atrial Appendage Closure (LAAC) Device Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportLeflunomide Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportLefamulin Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportLED X-Ray Film Viewers Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportLED Veterinary Endoscopes Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportLED Vein Finders Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportLED Therapy Masks Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportLED Surgical Shadowless Lights Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportLED Surgical Lights Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportLED Surgical Headlights Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportLED Shadowless Surgical Lamps Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.